Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
26 Feb 2020
Historique:
received: 28 01 2020
revised: 21 02 2020
accepted: 24 02 2020
entrez: 1 3 2020
pubmed: 1 3 2020
medline: 15 12 2020
Statut: epublish

Résumé

The atherogenicity of low-density lipoprotein (LDL) and triglyceride-rich lipoproteins (TRLs) may be more significant than LDL cholesterol levels. Clinical trials which have led to increased high-density lipoprotein (HDL) cholesterol have not always seen reductions in cardiovascular disease (CVD). Furthermore, genetic variants predisposing individuals to high HDL cholesterol are not associated with a lower risk of suffering a coronary event, and therefore HDL functionality is considered to be the most relevant aspect. Virgin olive oil (VOO) is thought to play a protective role against CVD. This review describes the effects of VOO and phenol-enriched VOOs on lipoprotein atherogenicity and HDL atheroprotective properties. The studies have demonstrated a decrease in LDL atherogenicity and an increase in the HDL-mediated macrophage cholesterol efflux capacity, HDL antioxidant activity, and HDL anti-inflammatory characteristics after various VOO interventions. Moreover, the expression of cholesterol efflux-related genes was enhanced after exposure to phenol-enriched VOOs in both post-prandial and sustained trials. Improvements in HDL antioxidant properties were also observed after VOO and phenol-enriched VOO interventions. Furthermore, some studies have demonstrated improved characteristics of TRL atherogenicity under postprandial conditions after VOO intake. Large-scale, long-term randomized clinical trials, and Mendelian analyses which assess the lipoprotein state and properties, are required to confirm these results.

Identifiants

pubmed: 32110861
pii: nu12030601
doi: 10.3390/nu12030601
pmc: PMC7146215
pii:
doi:

Substances chimiques

Antioxidants 0
Lipoproteins 0
Olive Oil 0
Phenols 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : Sara Borrell contract (CD17/00233)
Organisme : Instituto de Salud Carlos III
ID : FIS 16-00139
Organisme : Instituto de Salud Carlos III
ID : FIS 19-00136
Organisme : Instituto de Salud Carlos III
ID : CIBERDEM and CIBEROBN
Organisme : FEDER "Una manera de hacer Europa"
ID : (ISCIII)

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Front Biosci. 2006 May 01;11:1328-48
pubmed: 16368520
Circulation. 2009 Nov 24;120(21):2095-104
pubmed: 19901191
Atherosclerosis. 1997 Jun;131(2):161-6
pubmed: 9199268
Eur J Nutr. 2016 Mar;55(2):519-527
pubmed: 25733165
Clin Sci (Lond). 2010 Jun 15;119(6):251-61
pubmed: 20420579
Eur J Nutr. 2017 Feb;56(1):119-131
pubmed: 26541328
Circulation. 1977 May;55(5):767-72
pubmed: 191215
J Nutr Biochem. 2010 Jul;21(7):634-44
pubmed: 19576748
J Lipid Res. 2015 Aug;56(8):1519-30
pubmed: 25995210
Atherosclerosis. 2010 Jun;210(2):548-54
pubmed: 20022325
Ann Nutr Metab. 2005 May-Jun;49(3):196-201
pubmed: 16020940
PLoS One. 2015 Jun 10;10(6):e0129160
pubmed: 26061039
Curr Opin Lipidol. 1995 Oct;6(5):286-90
pubmed: 8520851
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2115-9
pubmed: 25060792
Acta Diabetol. 2002 Dec;39(4):215-20
pubmed: 12486496
J Am Coll Nutr. 2007 Feb;26(1):24-31
pubmed: 17353580
J Nutr Biochem. 2013 Jul;24(7):1334-9
pubmed: 23333095
J Thromb Haemost. 2003 Jun;1(6):1183-8
pubmed: 12871317
Br J Nutr. 2000 Feb;83(2):151-9
pubmed: 10743494
Biochemistry. 1999 May 11;38(19):5976-81
pubmed: 10320323
EMBO Mol Med. 2012 Apr;4(4):251-68
pubmed: 22431312
Shock. 2004 Mar;21(3):210-21
pubmed: 14770033
J Nutrigenet Nutrigenomics. 2014;7(1):48-60
pubmed: 25011605
J Biochem. 2006 Sep;140(3):383-91
pubmed: 16873395
PLoS One. 2008 Aug 20;3(8):e2986
pubmed: 18714375
N Engl J Med. 2012 Nov 29;367(22):2089-99
pubmed: 23126252
Mol Nutr Food Res. 2019 Mar;63(6):e1800847
pubmed: 30628167
N Engl J Med. 2011 Jan 13;364(2):127-35
pubmed: 21226578
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4
pubmed: 8265667
Clin Biochem. 2019 Nov;73:1-10
pubmed: 31351988
Am J Clin Nutr. 2018 Nov 1;108(5):963-970
pubmed: 30475968
J Nutr. 2004 Sep;134(9):2314-21
pubmed: 15333722
N Engl J Med. 2007 Nov 22;357(21):2109-22
pubmed: 17984165
Circulation. 2017 Feb 14;135(7):633-643
pubmed: 28193797
Am J Clin Nutr. 2004 Dec;80(6):1487-91
pubmed: 15585759
Thromb Haemost. 1998 Aug;80(2):316-20
pubmed: 9716159
J Cardiovasc Med (Hagerstown). 2019 Jul;20(7):419-426
pubmed: 31593559
Am J Clin Nutr. 2003 Mar;77(3):605-11
pubmed: 12600850
Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1595-600
pubmed: 12842838
Biochim Biophys Acta. 1987 Jun 24;906(2):223-76
pubmed: 3297153
Pharmacol Rev. 2006 Sep;58(3):342-74
pubmed: 16968945
Br J Nutr. 2013 May 28;109(10):1844-55
pubmed: 23051557
J Biol Chem. 1995 Nov 10;270(45):26910-7
pubmed: 7592936
PLoS One. 2013;8(1):e55231
pubmed: 23383120
J Agric Food Chem. 2001 Nov;49(11):5653-61
pubmed: 11714373
FEBS J. 2006 Dec;273(24):5632-40
pubmed: 17096688
Br J Nutr. 2006 May;95(5):889-97
pubmed: 16611378
Am J Hypertens. 2012 Dec;25(12):1299-304
pubmed: 22914255
N Engl J Med. 2014 Dec 18;371(25):2383-93
pubmed: 25404125
Atherosclerosis. 2011 Sep;218(1):226-32
pubmed: 21641598
Circ Res. 2004 Oct 15;95(8):764-72
pubmed: 15486323
FASEB J. 2010 Jul;24(7):2546-57
pubmed: 20179144
Clin Chim Acta. 2013 Jun 5;421:51-6
pubmed: 23428589
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77
pubmed: 24558110
Free Radic Biol Med. 1997;22(1-2):57-71
pubmed: 8958130
Atherosclerosis. 2001 Nov;159(1):103-15
pubmed: 11689212
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
J Nutr. 2015 Aug;145(8):1692-7
pubmed: 26136585
Arterioscler Thromb Vasc Biol. 2005 May;25(5):923-31
pubmed: 15731492
Mol Nutr Food Res. 2017 Dec;61(12):
pubmed: 28887843
Nat Rev Cardiol. 2016 Jan;13(1):48-60
pubmed: 26323267
Arterioscler Thromb. 1991 May-Jun;11(3):653-62
pubmed: 2029503
Metabolism. 2000 Dec;49(12):1511-7
pubmed: 11145109
Ann Intern Med. 2006 Sep 5;145(5):333-41
pubmed: 16954359
Life Sci. 2003 Feb 21;72(14):1643-54
pubmed: 12551753
Biochem Soc Trans. 2003 Oct;31(Pt 5):1080-4
pubmed: 14505484
Circulation. 2020 Feb 11;141(6):444-453
pubmed: 31941372
Mol Nutr Food Res. 2012 Mar;56(3):510-4
pubmed: 22162245
Atherosclerosis. 1999 Nov 1;147(1):87-94
pubmed: 10525129
J Diabetes Complications. 2001 Sep-Oct;15(5):265-9
pubmed: 11522502
Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):352-60
pubmed: 16216721
Eur J Nutr. 2019 Sep;58(6):2545-2560
pubmed: 30094646
J Clin Invest. 2004 Feb;113(4):569-81
pubmed: 14966566
J Biol Chem. 1990 Dec 5;265(34):20739-46
pubmed: 1701170
Clin Chim Acta. 2016 Apr 1;455:134-48
pubmed: 26868089
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):448-54
pubmed: 25477346
J Hum Hypertens. 1990 Jun;4(3):227-33
pubmed: 1972963
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1696-705
pubmed: 23520163
Am Heart J. 1987 Feb;113(2 Pt 2):589-97
pubmed: 3544775
Eur J Clin Invest. 2003 Dec;33(12):1051-69
pubmed: 14636288
J Lipid Res. 2001 Feb;42(2):309-13
pubmed: 11181762
Clin Nutr. 2001 Jun;20(3):211-5
pubmed: 11407867
Mol Nutr Food Res. 2017 Sep;61(9):
pubmed: 28371298
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):929-39
pubmed: 24787907
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1333-41
pubmed: 21474825
J Agric Food Chem. 2015 Aug 5;63(30):6731-8
pubmed: 26184645
Lipids Health Dis. 2016 Aug 24;15(1):134
pubmed: 27558696
Metabolism. 2009 Feb;58(2):186-95
pubmed: 19154951
Atherosclerosis. 2007 Oct;194(2):372-82
pubmed: 17141784
Food Chem. 2015 Jan 15;167:30-5
pubmed: 25148955
Circ Res. 2001 Apr 27;88(8):756-62
pubmed: 11325866
J Nutr. 2001 Jan;131(1):59-65
pubmed: 11208939
JAMA. 1986 Nov 28;256(20):2835-8
pubmed: 3773200
Food Chem Toxicol. 2000 Aug;38(8):647-59
pubmed: 10908812
J Nutr. 2004 Dec;134(12):3284-9
pubmed: 15570026
Lancet. 2012 Aug 11;380(9841):572-80
pubmed: 22607825
Am J Clin Nutr. 2002 Nov;76(5):942-9
pubmed: 12399264
Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1046-53
pubmed: 9672064
Nutr Metab Cardiovasc Dis. 2000 Jun;10(3):121-5
pubmed: 11006920
N Engl J Med. 2018 Oct 04;379(14):1388-1389
pubmed: 30281995
J Nutr. 2002 Dec;132(12):3642-9
pubmed: 12468601
Circulation. 2001 May 8;103(18):2283-8
pubmed: 11342478
Mol Nutr Food Res. 2016 Jul;60(7):1544-54
pubmed: 26992050
J Biol Chem. 2004 Mar 26;279(13):12448-55
pubmed: 14718538
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8
pubmed: 20702809
Eur J Heart Fail. 2014 May;16(5):543-50
pubmed: 24574190
Atherosclerosis. 2005 Jul;181(1):149-58
pubmed: 15939067
Atherosclerosis. 2013 Oct;230(2):347-53
pubmed: 24075767
J Cardiovasc Risk. 2000 Oct;7(5):317-24
pubmed: 11143761
Mol Nutr Food Res. 2015 Sep;59(9):1758-70
pubmed: 26011257
Circulation. 2008 Oct 28;118(18):1837-47
pubmed: 18852364
Circulation. 2009 Apr 21;119(15):2103-11
pubmed: 19349317
J Clin Invest. 2016 Feb;126(2):796
pubmed: 26829628
Atherosclerosis. 2011 Sep;218(1):174-80
pubmed: 21640348
J Clin Invest. 1988 Dec;82(6):1884-93
pubmed: 3058748
Br J Nutr. 2013 Oct;110(7):1272-84
pubmed: 23510814
PLoS One. 2014 Aug 12;9(8):e104224
pubmed: 25117703
Life Sci. 1996;59(1):PL15-21
pubmed: 8684261
OMICS. 2009 Oct;13(5):431-8
pubmed: 19422291
Br J Nutr. 1997 Jan;77(1):19-31
pubmed: 9059227
Expert Opin Ther Targets. 2016 Aug;20(8):907-21
pubmed: 26854521
Br J Nutr. 2015 Apr;113 Suppl 2:S1-3
pubmed: 26148911
Eur J Biochem. 2001 Jul;268(14):3983-92
pubmed: 11453992
Med Clin (Barc). 2000 Sep 30;115(10):361-5
pubmed: 11262350
Clin Chim Acta. 2008 Apr;390(1-2):38-43
pubmed: 18206113
J Lipid Res. 2005 Aug;46(8):1643-51
pubmed: 15897606
Lancet. 2008 Jan 12;371(9607):117-25
pubmed: 18191683

Auteurs

Marta Farràs (M)

Molecular Bases of Cardiovascular Risk Group Institut de Recerca de l'Hospital Santa Creu i Sant Pau-Institut d'Investigacions Biomèdiques (IIB) Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029 Madrid, Spain.

Marina Canyelles (M)

Molecular Bases of Cardiovascular Risk Group Institut de Recerca de l'Hospital Santa Creu i Sant Pau-Institut d'Investigacions Biomèdiques (IIB) Sant Pau, 08041 Barcelona, Spain.
Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Departament de Bioquímica, Biologia Molecular i Biomedicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Montserrat Fitó (M)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain.

Joan Carles Escolà-Gil (JC)

Molecular Bases of Cardiovascular Risk Group Institut de Recerca de l'Hospital Santa Creu i Sant Pau-Institut d'Investigacions Biomèdiques (IIB) Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029 Madrid, Spain.
Departament de Bioquímica, Biologia Molecular i Biomedicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH